Medpace Holdings Inc vs ArcelorMittal SA — how do they compare? Medpace Holdings Inc trades at $607 (market cap $16.90B), while ArcelorMittal SA trades at $74.2 (market cap $55.88B). The key difference: ArcelorMittal SA is far larger — about 3.3× Medpace Holdings Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | MT | |
|---|---|---|
Market Cap | $16.90B | $55.88B |
Sector | Technology | Basic Materials |
52-Week High | $620.59 | $75.35 |
52-Week Low | $393.42 | $32.44 |
Enterprise Value | $16.52B | $65.45B |
Dividend Yield | — | 0.81% |
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →